These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 18167502

  • 21. Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.
    Connolly SJ, Crijns HJ, Torp-Pedersen C, van Eickels M, Gaudin C, Page RL, Hohnloser SH, ATHENA Investigators.
    Circulation; 2009 Sep 29; 120(13):1174-80. PubMed ID: 19752319
    [Abstract] [Full Text] [Related]

  • 22. Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (The European Rythmol/Rytmonorm Atrial Fibrillation Trial [ERAFT] Study).
    Meinertz T, Lip GY, Lombardi F, Sadowski ZP, Kalsch B, Camez A, Hewkin A, Eberle S, ERAFT Investigators.
    Am J Cardiol; 2002 Dec 15; 90(12):1300-6. PubMed ID: 12480038
    [Abstract] [Full Text] [Related]

  • 23. Prophylactic intravenous magnesium sulphate in addition to oral {beta}-blockade does not prevent atrial arrhythmias after coronary artery or valvular heart surgery: a randomized, controlled trial.
    Cook RC, Humphries KH, Gin K, Janusz MT, Slavik RS, Bernstein V, Tholin M, Lee MK.
    Circulation; 2009 Sep 15; 120(11 Suppl):S163-9. PubMed ID: 19752363
    [Abstract] [Full Text] [Related]

  • 24. [A randomized double-blind trial comparing cibenzoline and disopyramide in the prevention of recurrences of atrial tachyarrhythmia].
    Piot O, Flammang D, Dambrine P, Cheikel J, Jouannon C, Graux P, Baudouy Y, Bine-Scheck F, Leenhardt A.
    Arch Mal Coeur Vaiss; 1998 Dec 15; 91(12):1481-6. PubMed ID: 9891831
    [Abstract] [Full Text] [Related]

  • 25. Randomized placebo-controlled trial of propafenone for treatment of atrial tachyarrhythmias after cardiac surgery.
    Connolly SJ, Mulji AS, Hoffert DL, Davis C, Shragge BW.
    J Am Coll Cardiol; 1987 Nov 15; 10(5):1145-8. PubMed ID: 3499456
    [Abstract] [Full Text] [Related]

  • 26. A randomized trial evaluating amiodarone for prevention of atrial fibrillation after pulmonary resection.
    Tisdale JE, Wroblewski HA, Wall DS, Rieger KM, Hammoud ZT, Young JV, Kesler KA.
    Ann Thorac Surg; 2009 Sep 15; 88(3):886-93; discussion 894-5. PubMed ID: 19699916
    [Abstract] [Full Text] [Related]

  • 27. [Comparison of efficacy, safety and cost-effectiveness of intravenous versus oral propafenone in paroxysmal atrial fibrillation].
    Zadura M, Grossmann G, Modrzewska A, Klecha T, Klepacka H, Rumiński W.
    Pol Merkur Lekarski; 2001 Aug 15; 11(62):137-9. PubMed ID: 11757212
    [Abstract] [Full Text] [Related]

  • 28. Effect of CYP2D6 genetic polymorphism on peak propafenone concentration: no significant effect of CYP2D6*10.
    Doki K, Shirayama Y, Sekiguchi Y, Aonuma K, Kohda Y, Ieda M, Homma M.
    Pharmacogenomics; 2020 Dec 15; 21(18):1279-1288. PubMed ID: 33203295
    [Abstract] [Full Text] [Related]

  • 29. Amiodarone versus Sotalol and Propafenone for prevention of immediate recurrence of atrial fibrillation after internal cardioversion: importance of P wave analysis.
    Gorenek B, Cavusoglu Y, Goktekin O, Birdane A, Kudaiberdieva G, Ata N, Unalir A, Timuralp B.
    Int J Cardiol; 2006 Jan 13; 106(2):268-9. PubMed ID: 16321704
    [No Abstract] [Full Text] [Related]

  • 30. Efficacy and safety of sustained-release propafenone (propafenone SR) for patients with atrial fibrillation.
    Pritchett EL, Page RL, Carlson M, Undesser K, Fava G, Rythmol Atrial Fibrillation Trial (RAFT) Investigators.
    Am J Cardiol; 2003 Oct 15; 92(8):941-6. PubMed ID: 14556870
    [Abstract] [Full Text] [Related]

  • 31. [Efficacy and tolerance of propafenone in the prevention after a year of recurrent atrial arrhythmia. Results of a multicenter study of 114 patients].
    Sirinelli A, Maarek-Charbit M, Motté G.
    Ann Cardiol Angeiol (Paris); 1992 Sep 15; 41(7):419-23. PubMed ID: 1285631
    [Abstract] [Full Text] [Related]

  • 32. Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomised trial.
    Mahesh B, Yim B, Robson D, Pillai R, Ratnatunga C, Pigott D.
    Eur J Cardiothorac Surg; 2008 Mar 15; 33(3):370-6. PubMed ID: 18243724
    [Abstract] [Full Text] [Related]

  • 33. Efficacy and safety of dofetilide in the prevention of symptomatic episodes of paroxysmal supraventricular tachycardia: a 6-month double-blind comparison with propafenone and placebo.
    Tendera M, Wnuk-Wojnar AM, Kulakowski P, Malolepszy J, Kozlowski JW, Krzeminska-Pakula M, Szechinski J, Droszcz W, Kawecka-Jaszcz K, Swiatecka G, Ruzyllo W, Graff O.
    Am Heart J; 2001 Jul 15; 142(1):93-8. PubMed ID: 11431663
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of CYP2D6 oxidation of dextromethorphan and propafenone in a Chinese population with atrial fibrillation.
    Chow MS, White CM, Lau CP, Fan C, Tang MO.
    J Clin Pharmacol; 2001 Jan 15; 41(1):92-6. PubMed ID: 11144999
    [Abstract] [Full Text] [Related]

  • 35. Efficacy of substituting innovator propafenone for its generic formulation in patients with atrial fibrillation.
    Amit G, Rosen A, Wagshal AB, Bonneh DY, Liss T, Grosbard A, Ilia R, Katz A.
    Am J Cardiol; 2004 Jun 15; 93(12):1558-60. PubMed ID: 15194037
    [Abstract] [Full Text] [Related]

  • 36. Comparative evaluation of effect of valsartan/amlodipine and atenolol/amlodipine combinations on atrial fibrillation recurrence in hypertensive patients with type 2 diabetes mellitus.
    Fogari R, Zoppi A, Mugellini A, Corradi L, Lazzari P, Preti P, Derosa G.
    J Cardiovasc Pharmacol; 2008 Mar 15; 51(3):217-22. PubMed ID: 18356684
    [Abstract] [Full Text] [Related]

  • 37. Deglutition induced atrial tachycardia and atrial fibrillation.
    Kanjwal Y, Imran N, Grubb B.
    Pacing Clin Electrophysiol; 2007 Dec 15; 30(12):1575-8. PubMed ID: 18070318
    [Abstract] [Full Text] [Related]

  • 38. The influence of CYP2D6 polymorphism on the antiarrhythmic efficacy of propafenone in patients with paroxysmal atrial fibrillation during 3 months propafenone prophylactic treatment.
    Jazwinska-Tarnawska E, Orzechowska-Juzwenko K, Niewinski P, Rzemislawska Z, Loboz-Grudzien K, Dmochowska-Perz M, Slawin J.
    Int J Clin Pharmacol Ther; 2001 Jul 15; 39(7):288-92. PubMed ID: 11471772
    [Abstract] [Full Text] [Related]

  • 39. Simultaneous modeling of pharmacokinetics and pharmacodynamics of propafenone in healthy subjects.
    Cai WM, Zhang YD, Chen B, Cai MH, Luo JP, Ling SS.
    Acta Pharmacol Sin; 2001 Oct 15; 22(10):956-60. PubMed ID: 11749782
    [Abstract] [Full Text] [Related]

  • 40. Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy.
    Pritchett EL, McCarthy EA, Wilkinson WE.
    Ann Intern Med; 1991 Apr 01; 114(7):539-44. PubMed ID: 2001087
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.